Hang Lung Properties (HLPPY)
(Delayed Data from OTC)
$4.54 USD
-0.75 (-14.18%)
Updated Oct 8, 2024 03:51 PM ET
2-Buy of 5 2
C Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Hang Lung Properties Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,317 | 1,321 | 1,328 | 1,157 | 1,130 |
Cost Of Goods | 374 | 395 | 380 | 321 | 302 |
Gross Profit | 944 | 926 | 949 | 835 | 828 |
Selling & Adminstrative & Depr. & Amort Expenses | 81 | 125 | 10 | 921 | -1,048 |
Income After Depreciation & Amortization | 862 | 801 | 939 | -86 | 1,876 |
Non-Operating Income | 14 | 11 | 10 | -3 | 20 |
Interest Expense | 88 | 65 | 63 | 22 | 6 |
Pretax Income | 788 | 747 | 886 | -111 | 1,890 |
Income Taxes | 201 | 186 | 268 | 154 | 639 |
Minority Interest | 80 | 72 | 121 | 66 | 463 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 587 | 562 | 618 | -265 | 1,250 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 507 | 490 | 498 | -331 | 788 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 874 | 811 | 947 | -79 | 1,882 |
Depreciation & Amortization (Cash Flow) | 11 | 10 | 8 | 6 | 6 |
Income After Depreciation & Amortization | 862 | 801 | 939 | -86 | 1,876 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 902.27 | 899.85 | 899.76 | 902.11 | 899.54 |
Diluted EPS Before Non-Recurring Items | 0.59 | 0.59 | 0.62 | 0.60 | 0.63 |
Diluted Net EPS (GAAP) | 0.56 | 0.54 | 0.55 | -0.37 | 0.87 |
Fiscal Year end for Hang Lung Properties Ltd falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |